Prevalence of Fosfomycin Resistance among CTX-M-Producing Escherichia coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying Enzymes

Antimicrobial Agents and Chemotherapy
2010.0

Abstract

We evaluated the in vitro activity of fosfomycin against a total of 192 CTX-M beta-lactamase-producing Escherichia coli strains isolated in 70 Japanese clinical settings. Most of the isolates (96.4%) were found to be susceptible to fosfomycin. On the other hand, some of the resistant isolates were confirmed to harbor the novel transferable fosfomycin resistance determinants named FosA3 and FosC2, which efficaciously inactivate fosfomycin through glutathione S-transferase activity.

Knowledge Graph

Similar Paper

Prevalence of Fosfomycin Resistance among CTX-M-Producing Escherichia coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying Enzymes
Antimicrobial Agents and Chemotherapy 2010.0
Oral and Parenteral Therapeutic Options for Outpatient Urinary Infections Caused byEnterobacteriaceaeProducing CTX-M Extended-Spectrum β-Lactamases
Antimicrobial Agents and Chemotherapy 2009.0
Synthesis and biological evaluation of phosphate isosters of fosmidomycin and analogs as inhibitors of Escherichia coli and Mycobacterium smegmatis 1-deoxyxylulose 5-phosphate reductoisomerases
Bioorganic & Medicinal Chemistry 2017.0
Identification and Characterization of CTX-M-Producing Shigella Isolates in the United States
Antimicrobial Agents and Chemotherapy 2010.0
Plasmid-Mediated Resistance to Cephalosporins in Salmonella enterica Serovar Typhi
Antimicrobial Agents and Chemotherapy 2010.0
bla <sub>CTX-M</sub> Genes in Escherichia coli Strains from Croatian Hospitals Are Located in New ( bla <sub>CTX-M-3a</sub> ) and Widely Spread ( bla <sub>CTX-M-3a</sub> and bla <sub>CTX-M-15</sub> ) Genetic Structures
Antimicrobial Agents and Chemotherapy 2009.0
Characterization of Cefoxitin-Resistant Escherichia coli Isolates from Recreational Beaches and Private Drinking Water in Canada between 2004 and 2006
Antimicrobial Agents and Chemotherapy 2009.0
Aph(3′)-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia
Antimicrobial Agents and Chemotherapy 2007.0
Further Identification of CTX-M-2 Extended-Spectrum β-Lactamase in Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy 2009.0
Nationwide Investigation of Extended-Spectrum β-Lactamases, Metallo-β-Lactamases, and Extended-Spectrum Oxacillinases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Strains in France
Antimicrobial Agents and Chemotherapy 2010.0